EC Number | Activating Compound | Comment | Organism | Structure |
---|---|---|---|---|
2.3.1.B41 | 2-(3-chloro-(4-benzamido)phenyl)-1,3-dioxoisoindoline-5-carboxylic acid | i.e. CL-5A | Homo sapiens | |
2.3.1.B41 | 2-(3-chloro-4-(2,4,6-trichloro-N-(2,4,6-trichlorobenzoyl)benzamido)phenyl)-1,3-dioxoisoindoline-5-carboxylic acid | i.e. CL5D, SIRT6 displays ordered binding and CL5D does not improve H3K9ac binding | Homo sapiens | |
2.3.1.B41 | 2-(3-chloro-4-(2,4-dichlorobenzamido)phenyl)-1,3-dioxoisoindoline-5-carboxylic acid | i.e. CL-4 | Homo sapiens | |
2.3.1.B41 | 2-(3-chloro-4-(4-chlorobenzamido)phenyl)-1,3-dioxoisoindoline-5-carboxylic acid | i.e. CL-5B | Homo sapiens | |
2.3.1.B41 | 2-(4-benzamidophenyl)-1,3-dioxoisoindoline-5-carboxylic acid | i.e. CL-5 | Homo sapiens | |
2.3.1.B41 | 2-fluoropalmitic acid | - |
Homo sapiens | |
2.3.1.B41 | arachidonic acid | - |
Homo sapiens | |
2.3.1.B41 | arotinoid acid | i.e. TTNPB | Homo sapiens | |
2.3.1.B41 | eicosatrienoic acid | - |
Homo sapiens | |
2.3.1.B41 | L-NASPA | - |
Homo sapiens | |
2.3.1.B41 | lysophosphatidic acid | highly activating | Homo sapiens | |
2.3.1.B41 | mead acid | - |
Homo sapiens | |
2.3.1.B41 | additional information | screening for SIRT6 activator small molecules, dose-response and Michaelis-Menten parameters of activation by the SIRT6 activators, overview. Structure-activity relationship analysis yields activators with improved potency and selectivity for SIRT6. Enzyme residue Arg65 is critical for activation by facilitating a conformational step that initiates chemical catalysis. Arg65 mediates a conformational change after substrate binding and that the rate of this change is enhanced by small-molecule activation of deacetylation and during demyristoylation | Homo sapiens | |
2.3.1.B41 | N-linoleoylglycine | - |
Homo sapiens |
EC Number | Protein Variants | Comment | Organism |
---|---|---|---|
2.3.1.B41 | K160A | site-directed mutagenesis, the mutant's activability is similar compared to the wild-type enzyme | Homo sapiens |
2.3.1.B41 | K81A | site-directed mutagenesis, the activability of the mutant is only slightly reduced compared to the wild-type enzyme | Homo sapiens |
2.3.1.B41 | R65A | site-directed mutagenesis, the SIRT6 variant cannot be stimulated toward deacetylation by activator compounds. The R65A variant is similarly deficient in the ability to display enhanced catalysis with myristoylated substrates, suggesting that common catalytic steps are hampered | Homo sapiens |
2.3.1.B41 | R76A | site-directed mutagenesis, the activability of the mutant is only slightly reduced compared to the wild-type enzyme | Homo sapiens |
EC Number | KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|---|
2.3.1.B41 | additional information | - |
additional information | steady-state kinetic analysis of wild-type and mutant enzymes | Homo sapiens | |
2.3.1.B41 | 0.0028 | - |
[histone H3 peptide]-N6-acetyl-L-lysine9 | pH 7.5, 37°C, wild-type enzyme, in presence of activator lysophosphatidic acid | Homo sapiens | |
2.3.1.B41 | 0.0052 | - |
[histone H3 peptide]-N6-acetyl-L-lysine9 | pH 7.5, 37°C, wild-type enzyme, in presence of activator 2-(3-chloro-4-(2,4,6-trichloro-N-(2,4,6-trichlorobenzoyl)benzamido)phenyl)-1,3-dioxoisoindoline-5-carboxylic acid | Homo sapiens | |
2.3.1.B41 | 0.0094 | - |
[histone H3 peptide]-N6-acetyl-L-lysine9 | pH 7.5, 37°C, wild-type enzyme, in presence of activator N-linoleoylglycine | Homo sapiens | |
2.3.1.B41 | 0.015 | - |
[histone H3 peptide]-N6-acetyl-L-lysine9 | pH 7.5, 37°C, wild-type enzyme, in presence of activator arotinoid acid | Homo sapiens | |
2.3.1.B41 | 0.247 | - |
[histone H3 peptide]-N6-acetyl-L-lysine9 | pH 7.5, 37°C, wild-type enzyme | Homo sapiens | |
2.3.1.B41 | 0.47 | - |
[histone H3 peptide]-N6-acetyl-L-lysine9 | pH 7.5, 37°C, wild-type enzyme, mutant R65A | Homo sapiens |
EC Number | Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|---|
2.3.1.B41 | nucleus | - |
Homo sapiens | 5634 | - |
EC Number | Metals/Ions | Comment | Organism | Structure |
---|---|---|---|---|
2.3.1.B41 | Mg2+ | required | Homo sapiens |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.3.1.B41 | NAD+ + [histone H3 peptide]-N6-acetyl-L-lysine9 | Homo sapiens | - |
nicotinamide + [histone H3 peptide]-L-lysine9 + 2'-O-acetyl-ADP-ribose | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.3.1.B41 | Homo sapiens | Q8N6T7 | - |
- |
EC Number | Posttranslational Modification | Comment | Organism |
---|---|---|---|
2.3.1.B41 | lipoprotein | myristic acid is a competitive inhibitor of SIRT6 demyristoylation | Homo sapiens |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
2.3.1.B41 | HEK-293 cell | - |
Homo sapiens | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.3.1.B41 | NAD+ + [histone H3 peptide]-N6-acetyl-L-lysine9 | - |
Homo sapiens | nicotinamide + [histone H3 peptide]-L-lysine9 + 2'-O-acetyl-ADP-ribose | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
2.3.1.B41 | histone deacetylase sirtuin 6 | - |
Homo sapiens |
2.3.1.B41 | NAD-dependent protein deacetylase sirtuin-6 | UniProt | Homo sapiens |
2.3.1.B41 | SIRT6 | - |
Homo sapiens |
2.3.1.B41 | sirtuin 6 | - |
Homo sapiens |
EC Number | Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|---|
2.3.1.B41 | 37 | - |
assay at | Homo sapiens |
EC Number | Turnover Number Minimum [1/s] | Turnover Number Maximum [1/s] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|---|
2.3.1.B41 | 0.0001 | - |
[histone H3 peptide]-N6-acetyl-L-lysine9 | pH 7.5, 37°C, wild-type enzyme, mutant R65A | Homo sapiens | |
2.3.1.B41 | 1.1 | - |
[histone H3 peptide]-N6-acetyl-L-lysine9 | pH 7.5, 37°C, wild-type enzyme | Homo sapiens | |
2.3.1.B41 | 1.5 | - |
[histone H3 peptide]-N6-acetyl-L-lysine9 | pH 7.5, 37°C, wild-type enzyme, in presence of activator 2-(3-chloro-4-(2,4,6-trichloro-N-(2,4,6-trichlorobenzoyl)benzamido)phenyl)-1,3-dioxoisoindoline-5-carboxylic acid | Homo sapiens | |
2.3.1.B41 | 2.8 | - |
[histone H3 peptide]-N6-acetyl-L-lysine9 | pH 7.5, 37°C, wild-type enzyme, in presence of activator arotinoid acid | Homo sapiens | |
2.3.1.B41 | 2.8 | - |
[histone H3 peptide]-N6-acetyl-L-lysine9 | pH 7.5, 37°C, wild-type enzyme, in presence of activator N-linoleoylglycine | Homo sapiens | |
2.3.1.B41 | 3.2 | - |
[histone H3 peptide]-N6-acetyl-L-lysine9 | pH 7.5, 37°C, wild-type enzyme, in presence of activator lysophosphatidic acid | Homo sapiens |
EC Number | pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|---|
2.3.1.B41 | 7.5 | - |
assay at | Homo sapiens |
EC Number | General Information | Comment | Organism |
---|---|---|---|
2.3.1.B41 | evolution | sirtuins are an evolutionarily conserved family of proteins originally defined as the class III histone deacetylases (HDACs). The sirtuin family of proteins share a conserved central catalytic domain and the ability to couple the cleavage of NAD+ to the removal of an acyl group from the epsilon-amino group of lysines. Each family member (SIRT1-7) contains variable N-terminal and C-terminal domains and has diverse subcellular localization and function | Homo sapiens |
2.3.1.B41 | additional information | mechanisms of activated lysine deacetylation and enhanced long-chain acyl group removal by SIRT6, structure-activity relationship analysis, overview. Enzyme residue Arg65 is critical for activation by facilitating a conformational step that initiates chemical catalysis. Mechanism of SIRT6-catalyzed deacylation, overview. The substrate acyl-oxygen performs nucleophilic addition on the 1'-carbon of the nicotinamide ribose, resulting in the C1'-O-alkylamidate intermediate and release of nicotinamide. His133 acts as a general base to facilitate the intramolecular nucleophilic attack of the nicotinamide ribose 2'-hydroxyl on the O-alkylamidate carbon, affording the 1',2'-cyclic intermediate. Water-catalyzed hydrolysis of the 1',2'-cyclic intermediate yields the tetrahedral intermediate. Positively charged His133 donates a proton to the imino group of the tetrahedral intermediate, resulting in cleavage of the C-N bond and yielding the final products. O-acyl-ADPr and deacetylated lysine products are released from SIRT6 | Homo sapiens |
2.3.1.B41 | physiological function | sirtuins can deacetylate histones, and can deacetylate diverse protein substrates and regulate many processes, including metabolism and cellular stress response. Each sirtuin uniquely accommodates varying long-chain acyl substrates. SIRT6, for example, has an elongated hydrophobic pocket and is hundreds-fold more catalytically efficient toward long-chain (e.g. myristoylated) peptide substrates compared with acetylated peptide substrates | Homo sapiens |
EC Number | kcat/KM Value [1/mMs-1] | kcat/KM Value Maximum [1/mMs-1] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|---|
2.3.1.B41 | 0.00021 | - |
[histone H3 peptide]-N6-acetyl-L-lysine9 | pH 7.5, 37°C, wild-type enzyme, mutant R65A | Homo sapiens | |
2.3.1.B41 | 4.45 | - |
[histone H3 peptide]-N6-acetyl-L-lysine9 | pH 7.5, 37°C, wild-type enzyme | Homo sapiens | |
2.3.1.B41 | 186.7 | - |
[histone H3 peptide]-N6-acetyl-L-lysine9 | pH 7.5, 37°C, wild-type enzyme, in presence of activator arotinoid acid | Homo sapiens | |
2.3.1.B41 | 288.5 | - |
[histone H3 peptide]-N6-acetyl-L-lysine9 | pH 7.5, 37°C, wild-type enzyme, in presence of activator 2-(3-chloro-4-(2,4,6-trichloro-N-(2,4,6-trichlorobenzoyl)benzamido)phenyl)-1,3-dioxoisoindoline-5-carboxylic acid | Homo sapiens | |
2.3.1.B41 | 297.9 | - |
[histone H3 peptide]-N6-acetyl-L-lysine9 | pH 7.5, 37°C, wild-type enzyme, in presence of activator N-linoleoylglycine | Homo sapiens | |
2.3.1.B41 | 1142.9 | - |
[histone H3 peptide]-N6-acetyl-L-lysine9 | pH 7.5, 37°C, wild-type enzyme, in presence of activator lysophosphatidic acid | Homo sapiens |